Clinical Trial

Selatogrel Outcome Study in Suspected Acute Myocardial Infarction

Study acronym: SOS-AMI
Enrolling by Invitation Phase 3
View on ClinicalTrials.gov →
Summary
This study will randomize patients recently discharged from the hospital with a confirmed diagnosis of type 1 acute myocardial infarction (Thygesen et al. 2018) and having additional cardiovascular risk factors.
Protocol Amendment History 7 changes
notable Trial sites expanded: 813 -> 821 locations 2026-07-24
notable Primary completion pushed: 2026-12 -> 2027-07 2026-07-24
minor Completion pushed: 2026-12 -> 2027-07 2026-07-24
notable Trial sites expanded: 786 -> 813 locations 2026-06-18
notable Trial sites expanded: 738 -> 786 locations 2026-05-23
notable Enrollment increased: 14000 -> 25000 participants 2026-05-14
notable Trial sites expanded: 716 -> 738 locations 2026-05-01
Trial Details
NCT Number NCT04957719
Lead Sponsor Viatris Innovation GmbH
Conditions Acute Myocardial Infarction
Enrollment 25,000 participants
Start Date 2021-08-14
Primary Completion 2027-07 (estimated)
Study Completion 2027-07 (estimated)
Updated on ClinicalTrials.gov 2026-07-23